BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE

Scope & Guideline

Exploring Innovations in Experimental Biology and Medicine

Introduction

Welcome to the BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE information hub, where our guidelines provide a wealth of knowledge about the journal’s focus and academic contributions. This page includes an extensive look at the aims and scope of BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE, highlighting trending and emerging areas of study. We also examine declining topics to offer insight into academic interest shifts. Our curated list of highly cited topics and recent publications is part of our effort to guide scholars, using these guidelines to stay ahead in their research endeavors.
LanguageEnglish
ISSN0007-4888
PublisherSPRINGER
Support Open AccessNo
CountryUnited States
TypeJournal
Convergefrom 1956 to 2024
AbbreviationB EXP BIOL MED+ / Bull. Exp. Biol. Med.
Frequency12 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, NY 10004, UNITED STATES

Aims and Scopes

The BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE focuses on the intersection of biological and medical research, emphasizing experimental studies that elucidate mechanisms underlying health and disease. The journal prioritizes innovative approaches and methodologies that contribute to advancements in biological sciences and their medical applications.
  1. Experimental Biology:
    The journal encompasses a wide range of experimental biology studies, including cellular and molecular biology, emphasizing the experimental methods used to elucidate biological processes.
  2. Medical Applications:
    Research published in the journal often focuses on the medical implications of biological findings, bridging the gap between laboratory research and clinical practice.
  3. Translational Research:
    A significant emphasis is placed on translational research, where findings from basic science are applied to develop new therapeutic strategies or diagnostics.
  4. Innovative Therapeutics:
    The journal publishes studies on novel therapeutic approaches, including drug development, gene therapy, and the use of biomaterials in medical applications.
  5. Pathophysiology:
    Research exploring the underlying mechanisms of diseases, including cancer, metabolic disorders, and infectious diseases, is a core focus, contributing to the understanding of disease progression and potential interventions.
The BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE has seen the emergence of several trending themes over recent years, reflecting contemporary challenges and advancements in biomedical research. These themes highlight the journal's responsiveness to the evolving landscape of health and disease research.
  1. Immunotherapy and Cancer Research:
    A significant increase in studies focused on immunotherapy approaches for cancer treatment, including the exploration of immune checkpoint inhibitors and novel vaccine strategies.
  2. Microbiome Research:
    Research on the gut microbiome and its implications for health and disease has rapidly expanded, indicating a growing recognition of the microbiome's role in various conditions.
  3. Regenerative Medicine:
    Emerging studies in regenerative medicine, particularly those involving stem cells and tissue engineering, suggest a trend towards innovative therapeutic strategies for repairing damaged tissues.
  4. Neurodegenerative Diseases:
    An increased focus on the mechanisms and potential therapies for neurodegenerative diseases, reflecting a growing public health concern and research interest in this area.
  5. Chronic Diseases and Metabolic Disorders:
    Research addressing chronic diseases, particularly metabolic disorders such as diabetes and obesity, is on the rise, highlighting the need for effective interventions and management strategies.

Declining or Waning

As the field of experimental biology and medicine evolves, certain research themes have shown a decline in publication frequency within the BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE. This shift may reflect changing priorities in research funding, advancements in technology, or a greater emphasis on specific areas of study.
  1. Traditional Pharmacology Studies:
    There appears to be a waning interest in traditional pharmacology studies, particularly those that do not incorporate novel methodologies or insights into drug mechanisms.
  2. Basic Animal Models:
    While animal models remain essential, there is a noticeable decrease in studies solely relying on basic animal models without a strong translational component or innovative applications.
  3. In Vitro Studies Without Clinical Relevance:
    Research focusing solely on in vitro studies that do not connect to clinical applications or translational potential has decreased, indicating a shift towards more integrative research.

Similar Journals

Journal of Biological Research-Bollettino della Societa Italiana di Biologia Sperimentale

Unlocking the Secrets of Genetics and Molecular Biology
Publisher: PAGEPRESS PUBLISSN: 1826-8838Frequency: 2 issues/year

The Journal of Biological Research-Bollettino della Societa Italiana di Biologia Sperimentale is a premier peer-reviewed journal published by PAGEPRESS PUBL, focusing on a diverse array of topics within the broad field of biological research. Established as an Open Access journal since 2009, it facilitates the dissemination of scientific knowledge across the globe, enhancing visibility and accessibility for researchers, professionals, and students alike. With an ISSN of 1826-8838 and E-ISSN 2284-0230, this journal serves as a platform for innovative studies in Biochemistry, Genetics, and Molecular Biology, with a growing emphasis on Plant Science. Although currently categorized in the Q4 quartile for various sub-disciplines, the journal is dedicated to fostering interdisciplinary collaboration and advancing research quality. The latest Scopus rankings indicate a burgeoning presence in the academic community, positioning itself at significant ranks within the fields it covers. With publication coverage extending from 2011 to 2024, the journal aims to push the frontiers of biological research while adapting to the evolving demands of the scientific community.

M S-MEDECINE SCIENCES

Empowering research to transform medical landscapes.
Publisher: EDP SCIENCES S AISSN: 0767-0974Frequency: 12 issues/year

M S-MEDECINE SCIENCES, published by EDP SCIENCES S A, is an esteemed journal based in France dedicated to the fields of biochemistry, genetics, and medicine. With an ISSN of 0767-0974 and an E-ISSN of 1958-5381, this journal has been a platform for scholarly communication since its inception in 1990 and continues to present critical advancements in these scientific domains, aiming to bridge theoretical research with practical applications. Despite its current Q4 ranking in both Biochemistry, Genetics and Molecular Biology and Medicine categories, the journal aspires to enhance its visibility and impact within the academic community. Researchers and professionals can benefit from a wealth of studies that contribute to the understanding of complex biological systems and medical innovations. Interested authors are encouraged to explore the journal's submission guidelines and contribute to the growing body of knowledge in these important fields.

Frontiers in Bioscience-Landmark

Illuminating Pathways in Genetics and Immunology
Publisher: IMR PRESSISSN: 2768-6701Frequency: 12 issues/year

Frontiers in Bioscience-Landmark is a prestigious journal published by IMR PRESS that focuses on a diverse array of topics within the fields of biochemistry, genetics, molecular biology, immunology, and microbiology. With the ISSN 2768-6701 and E-ISSN 2768-6698, this journal has carved a significant niche since its inception in 1996, making its mark in contributions to the scientific community all the way through to 2024. Having achieved a respectable Q2 cohort rank in multiple categories, including biochemistry and immunology, it stands out for its impactful research, evidenced by its current Scopus rankings which highlight it as a vital resource for ongoing studies and advancements in the biosciences. Despite not being open access, the journal ensures that readers have access to high-quality research articles that are peer-reviewed and designed to foster academic discourse. The importance of Frontiers in Bioscience-Landmark lies in its commitment to disseminating innovative findings that can significantly enhance our understanding of biological sciences, making it an essential read for researchers, professionals, and students alike.

Cell Reports Medicine

Exploring the nexus of biochemistry and clinical practice.
Publisher: CELL PRESSISSN: 2666-3791Frequency: 12 issues/year

Cell Reports Medicine, published by Cell Press, represents a pivotal advancement in the open access landscape of biomedical research since its inception in 2020. With a dedicated focus on the intersection of medicine, biochemistry, genetics, and molecular biology, this journal has quickly established itself as a key resource, earning a remarkable Q1 ranking in these fields. Based in the United States, Cell Reports Medicine boasts impressive metrics, ranking #25 out of 636 in General Medicine and #18 out of 221 in Biochemistry, underscoring its influence and reach within the scientific community, with a notable 96th and 92nd percentile respectively. As a fully open access journal, it fosters global dissemination of knowledge, ensuring that groundbreaking research is readily available to researchers, professionals, and students alike. The journal not only promotes high-quality research but also aims to bridge the gap between molecular discoveries and clinical applications, making it an essential addition to any academic library or researcher's toolkit.

Biomolecules and Biomedicine

Pioneering Open Access to Transformative Biomedical Knowledge
Publisher: ASSOC BASIC MEDICAL SCI FEDERATION BOSNIA & HERZEGOVINA SARAJEVOISSN: 2831-0896Frequency: 6 issues/year

Biomolecules and Biomedicine is a pioneering open-access journal dedicated to advancing the fields of molecular biology and biomedical sciences, published by the Association of Basic Medical Science Federation Bosnia & Herzegovina in Sarajevo. With the ISSN 2831-0896 and the E-ISSN 2831-090X, this journal aims to facilitate the dissemination of high-quality research from 2023 onwards, inviting submissions that provide innovative insights and findings across various facets of medicine and biological sciences. Positioned within the General Medicine and Biochemistry, Genetics and Molecular Biology categories, it currently holds rankings of 332 out of 636 and 173 out of 221 respectively, highlighting its emerging influence in these fields. As an open-access journal, it ensures that all published research is freely accessible to a global audience, fostering collaboration and knowledge exchange among researchers, professionals, and students alike. With a commitment to enhancing scientific discourse and promoting cutting-edge research, Biomolecules and Biomedicine is poised to become a vital resource for those dedicated to unraveling the complexities of biomolecules and their roles in health and disease.

Animal Models and Experimental Medicine

Connecting researchers to enhance animal model applications.
Publisher: WILEYISSN: 2096-5451Frequency: 6 issues/year

Animal Models and Experimental Medicine is a prestigious open-access journal published by WILEY that has been a significant contribution to the field of biomedical research since its inception in 2018. Focusing on the role of animal models in the exploration of experimental medicine, the journal has garnered attention for its rigorous peer-reviewed articles that bridge laboratory research with clinical applications. The journal currently holds impressive quartile rankings, including Q1 in Medical Laboratory Technology, Veterinary (miscellaneous), and strong standings across various other categories, reflecting its reputable position within the Scopus rankings. With a commitment to disseminating high-quality research that advances knowledge and practice in veterinary and medical sciences, Animal Models and Experimental Medicine offers a platform for researchers, professionals, and students to contribute to and stay informed about pivotal developments in the field. As an open-access journal, it ensures accessibility, encouraging a wider readership and fostering collaboration among the scientific community.

Acta Naturae

Driving Innovation in Life Sciences Research
Publisher: RUSSIAN FEDERATION AGENCY SCIENCE & INNOVATIONISSN: 2075-8251Frequency: 4 issues/year

Acta Naturae is a peer-reviewed scientific journal published by the Russian Federation Agency for Science & Innovation, focusing on the dynamic fields of Biochemistry, Biotechnology, Molecular Biology, and Molecular Medicine. Launched in 2013, the journal has established a solid reputation in the academic community, with its articles contributing to essential advancements and discussions within these disciplines. By 2023, it has achieved notable rankings—including Q2 status in Biotechnology and Q3 in Biochemistry, Molecular Biology, and Molecular Medicine—indicating its growing influence and relevance in the scientific literature. While currently operating under a non-open access model, Acta Naturae invites researchers, professionals, and students to engage with its comprehensive research reports and reviews that span the breadth of molecular life sciences. With the aim of facilitating scientific dialogue and innovation, this journal serves as a key resource for those seeking to stay at the forefront of molecular research.

BIOMEDICAL PAPERS-OLOMOUC

Shaping the dialogue in biochemistry and genetics.
Publisher: PALACKY UNIV, MEDICAL FACISSN: 1213-8118Frequency: 4 issues/year

BIOMEDICAL PAPERS-OLOMOUC, published by Palacky University Medical Faculty, is a prominent open-access journal dedicated to advancing the fields of biochemistry, genetics, molecular biology, and general medicine. Since its inception in 2001, this journal has provided a vital platform for researchers, professionals, and students alike, fostering a collaborative environment for the dissemination of cutting-edge research findings. With a current impact factor reflected in its placement in the Q3 quartiles for both biochemistry and medicine categories, it demonstrates a growing influence in the academic community. The journal is indexed in Scopus, showcasing its relevance within the medical and biophysical sciences, and it operates in an open-access format to ensure broad accessibility of its articles. Set against the backdrop of Olomouc, Czech Republic, BIOMEDICAL PAPERS-OLOMOUC continues to contribute significantly to the global dialogue in biomedical research, making it an essential resource for anyone engaged in these dynamic and rapidly evolving fields.

EXPERIMENTAL AND MOLECULAR MEDICINE

Empowering researchers with open access to cutting-edge findings.
Publisher: SPRINGERNATUREISSN: 1226-3613Frequency: 12 issues/year

EXPERIMENTAL AND MOLECULAR MEDICINE, published by SpringerNature, is a premier open-access journal that has been at the forefront of biomedical research since its establishment in 1996. With a focus on innovative studies in biochemistry, molecular biology, and clinical biochemistry, the journal has consistently maintained a distinguished position within the top quartile (Q1) across multiple categories, underscoring its significant impact in these fields. The journal offers researchers and practitioners a platform for high-quality, peer-reviewed articles that advance our understanding of molecular mechanisms underlying health and disease. As a crucial resource for scholars seeking to explore cutting-edge research and practical advancements, its inclusion in relevant databases such as Scopus reflects an exceptional ranking with notable percentiles—placing it among the best in biomedical sciences. With a commitment to open access, EXPERIMENTAL AND MOLECULAR MEDICINE ensures that findings are readily available to the global academic community, facilitating collaboration and innovation in molecular medicine.

INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY

Exploring New Frontiers in Experimental Biology
Publisher: NATL INST SCIENCE COMMUNICATION-NISCAIRISSN: 0019-5189Frequency: 12 issues/year

INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY, published by the NATL INST SCIENCE COMMUNICATION-NISCAIR, stands as a significant platform for the dissemination of original research in the fields of biochemistry, genetics, and molecular biology, particularly within the context of Indian scientific advancements. With its ISSN 0019-5189 and E-ISSN 0975-1009, the journal has been an essential resource since its inception in 1965, although coverage in prominent databases like Scopus was discontinued in 2018. The journal ranks in the 57th percentile for Biotechnology, as well as in the 27th and 25th percentiles for Molecular Biology and Cell Biology respectively, underscoring its impact and relevance. While currently not an Open Access journal, it continues to provide valuable insights and contributions from researchers and professionals in the growing field of experimental biology. The esteemed contributions published in this journal enhance our understanding of biological processes and foster the development of innovative solutions to contemporary challenges in health and environmental science.